Smartinjector

By Heather Mack October 3, 2016
New York City based-startup Quio, which is working on a sensor-enabled drug injector and companion software for the clinical trial and chronic disease market, has raised $1.05 million in seed funding. The undisclosed investors include those with expertise in health insurance, pharmaceuticals and clinical research, the company revealed. Quio is developing Smartinjector, a connected medication...